Claudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancer

The expression of claudin-4, a protein involved in tight junction complexes, is widely dysregulated in epithelial malignancies. Claudin-4 is overexpressed in several premalignant precursor lesions, including those of cancers of the breast, pancreas, and prostate, and is associated with poor survival...

Full description

Bibliographic Details
Main Authors: Mosley, M, Knight, J, Neesse, A, Michl, P, Iezzi, M, Kersemans, V, Cornelissen, B
Format: Journal article
Language:English
Published: Society of Nuclear Medicine 2015
_version_ 1797075565930348544
author Mosley, M
Knight, J
Neesse, A
Michl, P
Iezzi, M
Kersemans, V
Cornelissen, B
author_facet Mosley, M
Knight, J
Neesse, A
Michl, P
Iezzi, M
Kersemans, V
Cornelissen, B
author_sort Mosley, M
collection OXFORD
description The expression of claudin-4, a protein involved in tight junction complexes, is widely dysregulated in epithelial malignancies. Claudin-4 is overexpressed in several premalignant precursor lesions, including those of cancers of the breast, pancreas, and prostate, and is associated with poor survival. A noncytotoxic C-terminal fragment of Clostridium perfringens enterotoxin (cCPE) is a natural ligand for claudin-4. Here, we demonstrate whole-body quantitative SPECT imaging of preneoplastic breast cancer tissue using (111)In-labeled cCPE.cCPE.GST or GST (GST is glutathione S-transferase) was conjugated to the metal ion chelator benzyl-diethylenetriaminepentaacetic acid to allow (111)In radiolabeling. The affinity of radiolabeled cCPE.GST for claudin-4 was confirmed using claudin-4-expressing MDA-MB-468 and SQ20b cells, compared with claudin-4-negative HT1080 cells. In vivo SPECT imaging was performed using athymic mice bearing MDA-MB-468 or HT1080 xenografts and using genetically modified BALB/neuT mice, which spontaneously develop claudin-4-expressing breast cancer lesions.The uptake of (111)In-cCPE.GST in claudin-4-positive MDA-MB-468 xenograft tumors in athymic mice was significantly higher than in (111)In-GST or claudin-4-negative HT1080 tumors (6.72 ± 0.18 vs. 3.88 ± 1.00 vs. 2.36 ± 1.25 percentage injected dose per gram [%ID/g]; P < 0.0001). No other significant differences were observed in any of the examined organs. BALB/neuT mice, expressing rat neuT under mmtv promotor control, spontaneously developed tumorous lesions within their mammary fat pads over the course of 130 d. Overt mammary tumors were claudin-4-positive, and (111)In-cCPE.GST uptake was 3.2 ± 0.70 %ID/g, significantly higher than (111)In-GST (1.00 ± 0.60 %ID/g; P < 0.05). Mammary fat pads in mice aged 80 d bore claudin-4-positive aplastic lesions and accumulated (111)In-cCPE.GST (3.17 ± 0.51 %ID/g) but not (111)In-GST (0.99 ± 0.39 %ID/g; P < 0.001).Taken together, (111)In-cCPE.GST targets claudin-4 expression in frank tumors and preneoplastic tissue, and cCPE imaging may be used as an early detection tool for breast, prostate, and pancreatic cancer.
first_indexed 2024-03-06T23:52:07Z
format Journal article
id oxford-uuid:72f4d701-0dc3-4623-be59-91532e6b8179
institution University of Oxford
language English
last_indexed 2024-03-06T23:52:07Z
publishDate 2015
publisher Society of Nuclear Medicine
record_format dspace
spelling oxford-uuid:72f4d701-0dc3-4623-be59-91532e6b81792022-03-26T19:53:27ZClaudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancerJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:72f4d701-0dc3-4623-be59-91532e6b8179EnglishSymplectic Elements at OxfordSociety of Nuclear Medicine2015Mosley, MKnight, JNeesse, AMichl, PIezzi, MKersemans, VCornelissen, BThe expression of claudin-4, a protein involved in tight junction complexes, is widely dysregulated in epithelial malignancies. Claudin-4 is overexpressed in several premalignant precursor lesions, including those of cancers of the breast, pancreas, and prostate, and is associated with poor survival. A noncytotoxic C-terminal fragment of Clostridium perfringens enterotoxin (cCPE) is a natural ligand for claudin-4. Here, we demonstrate whole-body quantitative SPECT imaging of preneoplastic breast cancer tissue using (111)In-labeled cCPE.cCPE.GST or GST (GST is glutathione S-transferase) was conjugated to the metal ion chelator benzyl-diethylenetriaminepentaacetic acid to allow (111)In radiolabeling. The affinity of radiolabeled cCPE.GST for claudin-4 was confirmed using claudin-4-expressing MDA-MB-468 and SQ20b cells, compared with claudin-4-negative HT1080 cells. In vivo SPECT imaging was performed using athymic mice bearing MDA-MB-468 or HT1080 xenografts and using genetically modified BALB/neuT mice, which spontaneously develop claudin-4-expressing breast cancer lesions.The uptake of (111)In-cCPE.GST in claudin-4-positive MDA-MB-468 xenograft tumors in athymic mice was significantly higher than in (111)In-GST or claudin-4-negative HT1080 tumors (6.72 ± 0.18 vs. 3.88 ± 1.00 vs. 2.36 ± 1.25 percentage injected dose per gram [%ID/g]; P < 0.0001). No other significant differences were observed in any of the examined organs. BALB/neuT mice, expressing rat neuT under mmtv promotor control, spontaneously developed tumorous lesions within their mammary fat pads over the course of 130 d. Overt mammary tumors were claudin-4-positive, and (111)In-cCPE.GST uptake was 3.2 ± 0.70 %ID/g, significantly higher than (111)In-GST (1.00 ± 0.60 %ID/g; P < 0.05). Mammary fat pads in mice aged 80 d bore claudin-4-positive aplastic lesions and accumulated (111)In-cCPE.GST (3.17 ± 0.51 %ID/g) but not (111)In-GST (0.99 ± 0.39 %ID/g; P < 0.001).Taken together, (111)In-cCPE.GST targets claudin-4 expression in frank tumors and preneoplastic tissue, and cCPE imaging may be used as an early detection tool for breast, prostate, and pancreatic cancer.
spellingShingle Mosley, M
Knight, J
Neesse, A
Michl, P
Iezzi, M
Kersemans, V
Cornelissen, B
Claudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancer
title Claudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancer
title_full Claudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancer
title_fullStr Claudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancer
title_full_unstemmed Claudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancer
title_short Claudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancer
title_sort claudin 4 spect imaging allows detection of aplastic lesions in a mouse model of breast cancer
work_keys_str_mv AT mosleym claudin4spectimagingallowsdetectionofaplasticlesionsinamousemodelofbreastcancer
AT knightj claudin4spectimagingallowsdetectionofaplasticlesionsinamousemodelofbreastcancer
AT neessea claudin4spectimagingallowsdetectionofaplasticlesionsinamousemodelofbreastcancer
AT michlp claudin4spectimagingallowsdetectionofaplasticlesionsinamousemodelofbreastcancer
AT iezzim claudin4spectimagingallowsdetectionofaplasticlesionsinamousemodelofbreastcancer
AT kersemansv claudin4spectimagingallowsdetectionofaplasticlesionsinamousemodelofbreastcancer
AT cornelissenb claudin4spectimagingallowsdetectionofaplasticlesionsinamousemodelofbreastcancer